Back to Search
Start Over
Antinociceptive effects of the combined use of butorphanol and buprenorphine in mice
- Source :
- Neuropsychopharmacology Reports
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Butorphanol and buprenorphine are mixed opioid receptor agonist‐antagonist drugs widely used as analgesics in people and animals. There are few reports concerning the interaction of multiple opioids, and their antinociceptive effects, when combined with other opioids, remain unclear. Therefore, we report the preliminary findings of the antinociceptive effects of the combined use of butorphanol and buprenorphine in C57BL/6JJcl mice. Both drugs were administered either simultaneously or in different orders. Compared with the baseline values, the tail‐flick and hot‐plate test latencies increased regardless of the order of administration. Furthermore, enhanced latencies were observed on administration of butorphanol followed by buprenorphine. Combined use of these drugs may not attenuate analgesic efficacy. Besides, enhancement of these effects can be obtained by changing the order of the administration of these drugs. It is necessary to further investigate the molecular basis of the underlying mechanism in future definitive studies.
- Subjects :
- medicine.drug_class
Butorphanol
Analgesic
Combined use
Micro Reports
Pharmacology
Micro Report
Mice
Opioid receptor
medicine
Animals
Humans
Pharmacology (medical)
antinociception
Baseline values
Analgesics
business.industry
buprenorphine
mixed opioid receptor agonist‐antagonist
Analgesics, Opioid
Mice, Inbred C57BL
Psychiatry and Mental health
Clinical Psychology
Nociception
business
medicine.drug
Buprenorphine
Subjects
Details
- ISSN :
- 2574173X
- Volume :
- 41
- Database :
- OpenAIRE
- Journal :
- Neuropsychopharmacology Reports
- Accession number :
- edsair.doi.dedup.....e209d81441944317f27521d9303c7975
- Full Text :
- https://doi.org/10.1002/npr2.12202